Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and Bromhexine for COVID-19
NCT04928495Phase 3Unknown
- Sponsor
- Federal University of Ceará
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, bromhexine in coronavirus disease 2019 (COVID-19), sponsored by Federal University of Ceará. Status: unknown.
02
Drugs
acetylcysteinebromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04928495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04928495.